Veritas Genetics
Veritas Genetics is a personal genomics startup based in Danvers, Massachusetts. It was co-founded in 2014 by George M. Church, Mirza Cifric, Preston Estep, and Jonathan Zhao. In 2018, the company launched its flagship product, myGenome, with the stated goal of providing consumers with information about their genetic risk for disease and allergic reactions based on whole-genome sequencing results. The company's decision to sell the product for only $199 per order during an initial period attracted media attention as this promotional price was far below traditional prices for consumer-grade genome sequencing at the  time. CNBC included the company on its Disruptor 50 list in 2018 and 2019. In December 2019, the company announced that it was ceasing U.S. operations and laying off most of its employees due to its inability to raise further funding. In January 2020, the company reversed course and announced that it had obtained further funding, would resume U.S. operations, and would rehire many of its employees.